Nonetheless, CRP is a nonspecific marker of inflammation, and additional studies of specific cytokines or factors that regulate acute-phase response are necessary to elucidate the mechanisms by which inflammation increases the risk of colon cancer. This evidence concerns the gene CRP and malignant colon neoplasm.